Mercer Global Advisors Inc Novo Nordisk A S Transaction History

Mercer Global Advisors Inc

  • $48.3 Billion
  • Q2 2025

A detailed history of Mercer Global Advisors Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Mercer Global Advisors Inc holds 168,903 shares of NVO stock, worth $7.86 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
168,903
Previous 171,048 1.25%
Holding current value
$7.86 Million
Previous $11.9 Million 1.85%
% of portfolio
0.02%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$58.08 - $81.05 $124,581 - $173,852
-2,145 Reduced 1.25%
168,903 $11.7 Million
Q1 2025

May 15, 2025
SELL
$69.3 - $90.95 $1.59 Million - $2.09 Million
-22,970 Reduced 11.84%
171,048 $11.9 Million
Q4 2024

Feb 14, 2025
SELL
$85.0 - $120.04 $2.3 Million - $3.24 Million
-27,011 Reduced 12.22%
194,018 $16.7 Million
Q3 2024

Nov 13, 2024
BUY
$119.07 - $145.42 $1.96 Million - $2.39 Million
16,448 Added 8.04%
221,029 $26.3 Million
Q2 2024

Aug 12, 2024
BUY
$122.71 - $146.91 $985,361 - $1.18 Million
8,030 Added 4.09%
204,581 $29.2 Million
Q1 2024

May 15, 2024
SELL
$102.11 - $135.92 $638,698 - $850,179
-6,255 Reduced 3.08%
196,551 $25.5 Million
Q4 2023

Feb 14, 2024
BUY
$87.78 - $105.45 $1.09 Million - $1.31 Million
12,430 Added 6.53%
202,806 $21 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $8.75 Million - $19.2 Million
96,214 Added 102.18%
190,376 $17.3 Million
Q2 2023

Aug 14, 2023
BUY
$155.98 - $172.65 $1.48 Million - $1.64 Million
9,507 Added 11.23%
94,162 $15.2 Million
Q1 2023

May 15, 2023
SELL
$132.34 - $159.14 $288,236 - $346,606
-2,178 Reduced 2.51%
84,655 $13.5 Million
Q4 2022

Feb 08, 2023
SELL
$102.55 - $135.33 $1.07 Million - $1.42 Million
-10,477 Reduced 10.77%
86,833 $11.8 Million
Q3 2022

Nov 15, 2022
SELL
$95.28 - $116.93 $182,461 - $223,920
-1,915 Reduced 1.93%
97,310 $9.7 Million
Q2 2022

Aug 10, 2022
BUY
$103.24 - $121.81 $978,715 - $1.15 Million
9,480 Added 10.56%
99,225 $11.1 Million
Q1 2022

May 10, 2022
SELL
$93.1 - $112.54 $1.07 Million - $1.29 Million
-11,463 Reduced 11.33%
89,745 $9.97 Million
Q4 2021

Feb 04, 2022
BUY
$95.88 - $117.08 $224,071 - $273,615
2,337 Added 2.36%
101,208 $11.3 Million
Q3 2021

Nov 10, 2021
BUY
$84.42 - $106.62 $841,160 - $1.06 Million
9,964 Added 11.21%
98,871 $9.49 Million
Q2 2021

Aug 10, 2021
BUY
$67.66 - $84.76 $252,371 - $316,154
3,730 Added 4.38%
88,907 $7.45 Million
Q1 2021

May 11, 2021
BUY
$67.06 - $75.82 $75,911 - $85,828
1,132 Added 1.35%
85,177 $5.74 Million
Q4 2020

Feb 12, 2021
BUY
$63.89 - $73.8 $136,149 - $157,267
2,131 Added 2.6%
84,045 $5.87 Million
Q3 2020

Dec 10, 2020
BUY
$63.69 - $70.22 $1.5 Million - $1.65 Million
23,534 Added 40.31%
81,914 $5.69 Million
Q2 2020

Aug 10, 2020
BUY
$58.54 - $67.94 $902,569 - $1.05 Million
15,418 Added 35.89%
58,380 $3.82 Million
Q1 2020

May 18, 2020
BUY
$49.46 - $64.78 $823,459 - $1.08 Million
16,649 Added 63.27%
42,962 $2.59 Million
Q4 2019

Feb 13, 2020
BUY
$49.86 - $58.26 $21,689 - $25,343
435 Added 1.68%
26,313 $1.52 Million
Q3 2019

Nov 12, 2019
BUY
$47.54 - $53.43 $161,778 - $181,822
3,403 Added 15.14%
25,878 $1.34 Million
Q2 2019

Aug 14, 2019
BUY
$46.79 - $52.47 $56,007 - $62,806
1,197 Added 5.63%
22,475 $1.15 Million
Q1 2019

Apr 23, 2019
SELL
$46.36 - $52.63 $138,477 - $157,205
-2,987 Reduced 12.31%
21,278 $1.11 Million
Q1 2019

Apr 12, 2019
BUY
$46.36 - $52.63 $1.12 Million - $1.28 Million
24,265 New
24,265 $1.12 Million

Others Institutions Holding NVO

# of Institutions
1,694
Shares Held
293M
Call Options Held
13.8M
Put Options Held
19.7M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $105B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email